Patent · US Active

Pyrrolo[1,2-b]pyridazine derivatives

US12415808B2 · kind B2 · utility

0Cited by
44References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 2022
Grant dateSep 16, 2025
Priority date—
Expiry dateNov 23, 2042

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof, wherein the variable substituents are disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.